⌘K
Loading ticker…
As of 2026-08-25, Intelligent Bio Solutions Inc. Common Stock (INBS) has a 3-month relative strength percentile of 30 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 35. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 12.6%, relative volume 0.53×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
INBS appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $19K notional.
Held by 1 ETFs · $19K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $19K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | INBS Jan avg: 75.85% median: 8.45% win: 50% σ: 168.06% n: 4 2022-10-28 → 2026-07-31 | INBS Feb avg: 2.61% median: -12.75% win: 50% σ: 75.10% n: 4 2022-10-28 → 2026-07-31 | INBS Mar avg: -31.77% median: -29.50% win: 0% σ: 15.59% n: 4 2022-10-28 → 2026-07-31 | INBS Apr avg: -22.84% median: -22.00% win: 0% σ: 11.02% n: 4 2022-10-28 → 2026-07-31 | INBS May avg: 4.04% median: 7.53% win: 75% σ: 11.70% n: 4 2022-10-28 → 2026-07-31 | INBS Jun avg: -1.29% median: -4.43% win: 50% σ: 17.60% n: 4 2022-10-28 → 2026-07-31 | INBS Jul avg: -22.81% median: -23.93% win: 0% σ: 11.37% n: 4 2022-10-28 → 2026-07-31 | INBS Aug avg: 0.17% median: 0.21% win: 67% σ: 2.38% n: 3 2022-10-28 → 2026-07-31 (current) | INBS Sep avg: -18.61% median: -37.04% win: 33% σ: 35.84% n: 3 2022-10-28 → 2026-07-31 | INBS Oct avg: -27.77% median: -13.90% win: 0% σ: 34.99% n: 4 2022-10-28 → 2026-07-31 | INBS Nov avg: 15.04% median: -0.81% win: 50% σ: 56.85% n: 4 2022-10-28 → 2026-07-31 | INBS Dec avg: -7.86% median: -16.02% win: 25% σ: 37.31% n: 4 2022-10-28 → 2026-07-31 |